The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy

2014 Update

L. B. Ramsey, S. G. Johnson, K. E. Caudle, C. E. Haidar, D. Voora, R. A. Wilke, W. D. Maxwell, L. McLeod, R. M. Krauss, D. M. Roden, Q. Feng, R. M. Cooper-DeHoff, L. Gong, T. E. Klein, M. Wadelius, Mikko Niemi

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalClinical Pharmacology and Therapeutics
Volume96
Issue number4
Pages (from-to)423-428
Number of pages6
ISSN0009-9236
DOIs
Publication statusPublished - Oct 2014
MoE publication typeA1 Journal article-refereed

Fields of Science

  • STATIN-INDUCED MYOPATHY
  • HIGH-RISK INDIVIDUALS
  • OATP-C
  • CONTROLLED-TRIAL
  • GENETIC VARIANT
  • PHARMACOKINETICS
  • ROSUVASTATIN
  • DRUG
  • POLYMORPHISMS
  • SLCO1B1-ASTERISK-5
  • 3111 Biomedicine

Cite this

Ramsey, L. B. ; Johnson, S. G. ; Caudle, K. E. ; Haidar, C. E. ; Voora, D. ; Wilke, R. A. ; Maxwell, W. D. ; McLeod, L. ; Krauss, R. M. ; Roden, D. M. ; Feng, Q. ; Cooper-DeHoff, R. M. ; Gong, L. ; Klein, T. E. ; Wadelius, M. ; Niemi, Mikko. / The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy : 2014 Update. In: Clinical Pharmacology and Therapeutics. 2014 ; Vol. 96, No. 4. pp. 423-428.
@article{f85b6809a62e4e228bb3492cdd059797,
title = "The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update",
keywords = "STATIN-INDUCED MYOPATHY, HIGH-RISK INDIVIDUALS, OATP-C, CONTROLLED-TRIAL, GENETIC VARIANT, PHARMACOKINETICS, ROSUVASTATIN, DRUG, POLYMORPHISMS, SLCO1B1-ASTERISK-5, 3111 Biomedicine",
author = "Ramsey, {L. B.} and Johnson, {S. G.} and Caudle, {K. E.} and Haidar, {C. E.} and D. Voora and Wilke, {R. A.} and Maxwell, {W. D.} and L. McLeod and Krauss, {R. M.} and Roden, {D. M.} and Q. Feng and Cooper-DeHoff, {R. M.} and L. Gong and Klein, {T. E.} and M. Wadelius and Mikko Niemi",
year = "2014",
month = "10",
doi = "10.1038/clpt.2014.125",
language = "English",
volume = "96",
pages = "423--428",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Wiley",
number = "4",

}

Ramsey, LB, Johnson, SG, Caudle, KE, Haidar, CE, Voora, D, Wilke, RA, Maxwell, WD, McLeod, L, Krauss, RM, Roden, DM, Feng, Q, Cooper-DeHoff, RM, Gong, L, Klein, TE, Wadelius, M & Niemi, M 2014, 'The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update', Clinical Pharmacology and Therapeutics, vol. 96, no. 4, pp. 423-428. https://doi.org/10.1038/clpt.2014.125

The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy : 2014 Update. / Ramsey, L. B.; Johnson, S. G.; Caudle, K. E.; Haidar, C. E.; Voora, D.; Wilke, R. A.; Maxwell, W. D.; McLeod, L.; Krauss, R. M.; Roden, D. M.; Feng, Q.; Cooper-DeHoff, R. M.; Gong, L.; Klein, T. E.; Wadelius, M.; Niemi, Mikko.

In: Clinical Pharmacology and Therapeutics, Vol. 96, No. 4, 10.2014, p. 423-428.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy

T2 - 2014 Update

AU - Ramsey, L. B.

AU - Johnson, S. G.

AU - Caudle, K. E.

AU - Haidar, C. E.

AU - Voora, D.

AU - Wilke, R. A.

AU - Maxwell, W. D.

AU - McLeod, L.

AU - Krauss, R. M.

AU - Roden, D. M.

AU - Feng, Q.

AU - Cooper-DeHoff, R. M.

AU - Gong, L.

AU - Klein, T. E.

AU - Wadelius, M.

AU - Niemi, Mikko

PY - 2014/10

Y1 - 2014/10

KW - STATIN-INDUCED MYOPATHY

KW - HIGH-RISK INDIVIDUALS

KW - OATP-C

KW - CONTROLLED-TRIAL

KW - GENETIC VARIANT

KW - PHARMACOKINETICS

KW - ROSUVASTATIN

KW - DRUG

KW - POLYMORPHISMS

KW - SLCO1B1-ASTERISK-5

KW - 3111 Biomedicine

U2 - 10.1038/clpt.2014.125

DO - 10.1038/clpt.2014.125

M3 - Article

VL - 96

SP - 423

EP - 428

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 4

ER -